PRPF19 and hepatocellular carcinoma: CircRNA-104797 regulated the cell-killing ability of sorafenib in HCC via binding to YBX1 in the cytoplasm and preventing the degradation of YBX1 mediated by PRP19 (Xu et al., 2020).